Hypoparathyroidism • Always Carry Spare Medication with You
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: the Effect on Keratinocyte Subpopulations
Acta Derm Venereol 2004; 84: 195–200 INVESTIGATIVE REPORT A Left/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in Patients with Psoriasis: The Effect on Keratinocyte Subpopulations Mannon E.J. FRANSSEN, Gys J. DE JONGH, Piet E.J. VAN ERP and Peter C.M. VAN DE KERKHOF Department of Dermatology, University Medical Centre Nijmegen, The Netherlands Vitamin D3 analogues are a first-line treatment of Calcipotriol (Daivonex1,50mg/g ointment, Leo chronic plaque psoriasis, but so far, comparative clinical Pharmaceutical Products, Denmark) has been investi- studies on calcipotriol and calcitriol ointment are sparse, gated intensively during the last decade, and has proven and in particular no comparative studies are available on to be a valuable tool in the management of chronic cell biological effects of these compounds in vivo. Using plaque psoriasis. A review by Ashcroft et al. (1), based on flow cytometric assessment, we investigated whether these a large number of randomized controlled trials, showed compounds had different effects on the composition and that calcipotriol was at least as effective as potent DNA synthesis of epidermal cell populations responsible topical corticosteroids, 1a,-25-dihydroxycholecalciferol for the psoriatic phenotype. For 8 weeks, 20 patients with (calcitriol), short-contact dithranol, tacalcitol and coal psoriasis vulgaris were treated twice daily with calcipo- tar. Recently, Scott et al. (2) presented an overview of triol and calcitriol ointment in a left/right comparative studies on the use of calcipotriol ointment in the study. Before and after treatment, clinical assessment of management of psoriasis. They reconfirmed the super- target lesions was performed, together with flow cyto- ior efficacy of a twice-daily calcipotriol ointment metric analysis of epidermal subpopulations with respect regimen to the treatments as mentioned above, and to keratin (K) 10, K6, vimentin and DNA distribution. -
Endocrine System WS19
Endocrine System Human Physiology Unit 3 Endocrine System • Various glands located throughout the body • Some organs may also have endocrine functions • Endocrine glands/organs synthesize and release hormones • Hormones travel in plasma to target cells Functions of the Endocrine System • Differentiation of nervous and reproductive system during fetal development • Regulation of growth and development • Regulation of the reproductive system • Maintains homeostasis • Responds to changes from resting state Mechanisms of Hormone Regulation • Hormones have different rates and rhythms of secretion • Hormones are regulated by feedback systems to maintain homeostasis • Receptors for hormones are only on specific effector cells • Excretion of hormones vary for steroid hormones and peptide hormones Regulation of Hormone Secretion • Release of hormones occurs in response to • A change from resting conditions • Maintaining a regulated level of hormones or substances • Hormone release is regulated by • Chemical factors (glucose, calcium) • Endocrine factors (tropic hormones, HPA) HPA = Hypothalamic-Pituitary Axis • Neural controls (sympathetic activation) Hormone Feedback Systems Negative feedback maintains hormone concentrations within physiological ranges • Negative feedback • Feedback to one level Loss of • Long-loop Negative Feedback feedback • Feedback to two levels control often leads to • Hypothalamus-Pituitary-Gland Axis pathology Negative Feedback Short-Loop Negative Feedback Long-Loop Negative Feedback Hormone Transport Peptide/Protein Hormones -
The Role of Reproductive Hormones in Epithelial Ovarian Carcinogenesis
H Gharwan et al. Hormones and epithelial 22:6 R339–R363 Review ovarian cancer The role of reproductive hormones in epithelial ovarian carcinogenesis Helen Gharwan1, Kristen P Bunch2,3 and Christina M Annunziata2 1National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, 12N226, Bethesda, Correspondence Maryland 20892-1906, USA should be addressed 2Women’s Malignancies Branch, National Cancer Institute, National Institutes of Health, Center for Cancer Research, to H Gharwan Bethesda, Maryland, USA Email 3Department of Gynecologic Oncology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA [email protected] Abstract Epithelial ovarian cancer comprises w85% of all ovarian cancer cases. Despite acceptance Key Words regarding the influence of reproductive hormones on ovarian cancer risk and considerable " ovarian cancer advances in the understanding of epithelial ovarian carcinogenesis on a molecular level, " hormone action complete understanding of the biologic processes underlying malignant transformation of " reproductive ovarian surface epithelium is lacking. Various hypotheses have been proposed over the past " immune several decades to explain the etiology of the disease. The role of reproductive hormones in " endocrine epithelial ovarian carcinogenesis remains a key topic of research. Primary questions in the field of ovarian cancer biology center on its developmental cell of origin, the positive and negative effects of each class of hormones on ovarian cancer initiation and progression, and the role of the immune system in the ovarian cancer microenvironment. The development of the female reproductive tract is dictated by the hormonal milieu during embryogenesis. Endocrine-Related Cancer Intensive research efforts have revealed that ovarian cancer is a heterogenous disease that may develop from multiple extra-ovarian tissues, including both Mu¨ llerian (fallopian tubes, endometrium) and non-Mu¨ llerian structures (gastrointestinal tissue), contributing to its heterogeneity and distinct histologic subtypes. -
Organ Transplant Manual
Congratulations! ystem lth S Hea sity iver Un 013 y, 2 Ma t© igh pyr Co Dear Patient: Congratulations! You have been given the gift of life! Receiving a transplant is a marvelous gift and the Transplant Team members will meet with you Transplant Team is here to assist you in taking care during your hospitalization to help you learn this of that gift. information. Here are some suggestions that may help you learn: Transplant Team members include the surgeons, medicine physicians, nurses, discharge coordinator, • Listen to the Transplant Team and ask them questions patient educator, dietitian, transplant pharmacists about things you don’t understand. and social workers. • Study every day. This manual is designed to help you care for yourself • Ask a family member or friend to study with you. following your transplant. As you read the following We want you to be able to return to your home and information, feel free to ask questions of your family in the best possible health to enjoy an active Transplant Team. and productive life. Understanding the information in this manual You must take your prescribed medications, follow is important. your diet, exercise, and monitor yourself for signs and symptoms of infection and rejection. By working as a team, you will achieve the best possible outcome from your transplant. Tim Nevil Kidney Recipient, 2001 Tania S. Gonzales José David Aguirre Liver Transplant Recipient, 2002 Liver Transplant Recipient, 2001 Table of Contents Organ Transplant Manual Contacting the Transplant Team When to Call ...........................................3 -
Study Guide Medical Terminology by Thea Liza Batan About the Author
Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails proficiencyincommunicatingwithhealthcareprofessionalssuchasphysicians,nurses, or dentists. -
Continuous Rhpth (1–34) Treatment in Chronic Hypoparathyroidism
ID: 20-0009 -20-0009 C T Fuss and others Continuous rhPTH (1-34) in ID: 20-0009; May 2020 hypoparathyroidism DOI: 10.1530/EDM-20-0009 Continuous rhPTH (1–34) treatment in chronic hypoparathyroidism Carmina Teresa Fuss1, Stephanie Burger-Stritt1, Silke Horn1, Ann-Cathrin Koschker1, Kathrin Frey1, Almuth Meyer2 and Stefanie Hahner1 Correspondence should be addressed 1Division of Endocrinology and Diabetology, Department of Medicine I, University Hospital Würzburg, Würzburg, to S Hahner Germany and 2Division of Endocrinology and Diabetology, Department of Internal Medicine, Helios Klinikum Erfurt, Email Erfurt, Germany [email protected] Summary Standard treatment of hypoparathyroidism consists of supplementation of calcium and vitamin D analogues, which does not fully restore calcium homeostasis. In some patients, hypoparathyroidism is refractory to standard treatment with persistent low serum calcium levels and associated clinical complications. Here, we report on three patients (58-year-oldmale,52-year-oldfemale,and48-year-oldfemale)sufferingfromseveretreatment-refractorypostsurgical hypoparathyroidism. Two patients had persistent hypocalcemia despite oral treatment with up to 4 µg calcitriol and up to 4 g calcium per day necessitating additional i.v. administration of calcium gluconate 2–3 times per week, whereas the third patient presented with high frequencies of hypocalcemic and treatment-associated hypercalcemic episodes. S.c. administration of rhPTH (1–34) twice daily (40 µg/day) or rhPTH (1–84) (100 µg/day) only temporarily increased serum calcium levels but did not lead to long-term stabilization. In all three cases, treatment with rhPTH (1–34) as continuous s.c. infusion via insulin pump was initiated. Normalization of serum calcium and serum phosphate levels was observed within 1 week at daily 1–34 parathyroid hormone doses of 15 µg to 29.4 µg. -
A Clinical Update on Vitamin D Deficiency and Secondary
References 1. Mehrotra R, Kermah D, Budoff M, et al. Hypovitaminosis D in chronic 17. Ennis JL, Worcester EM, Coe FL, Sprague SM. Current recommended 32. Thimachai P, Supasyndh O, Chaiprasert A, Satirapoj B. Efficacy of High 38. Kramer H, Berns JS, Choi MJ, et al. 25-Hydroxyvitamin D testing and kidney disease. Clin J Am Soc Nephrol. 2008;3:1144-1151. 25-hydroxyvitamin D targets for chronic kidney disease management vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin supplementation in CKD: an NKF-KDOQI controversies report. Am J may be too low. J Nephrol. 2016;29:63-70. D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD Kidney Dis. 2014;64:499-509. 2. Hollick MF. Vitamin D: importance in the prevention of cancers, type 1 with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial. diabetes, heart disease, and osteoporosis. Am J Clin Nutr 18. OPKO. OPKO diagnostics point-of-care system. Available at: http:// J Med Assoc Thai. 2015;98:643-648. 39. Jetter A, Egli A, Dawson-Hughes B, et al. Pharmacokinetics of oral 2004;79:362-371. www.opko.com/products/point-of-care-diagnostics/. Accessed vitamin D(3) and calcifediol. Bone. 2014;59:14-19. September 2 2015. 33. Kovesdy CP, Lu JL, Malakauskas SM, et al. Paricalcitol versus 3. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 40. Petkovich M, Melnick J, White J, et al. Modified-release oral calcifediol of vitamin D status and cancer incidence and mortality in men. -
Endocrine Paraneoplastic Syndromes: a Review
Endocrinology & Metabolism International Journal Review Article Open Access Endocrine paraneoplastic syndromes: a review Abstract Volume 1 Issue 1 - 2015 Paraneoplastic endocrine syndromes result from ectopic production of hormones by Hala Ahmadieh,1 Asma Arabi2 different tumors. Hypercalcemia of malignancy is the most common, mostly caused by 1Division of Endocrinology, American University of Beirut, ectopic parathyroid hormone related peptide (PTHrP) production which increases bone Lebanon resorption. Other causes include the rare ectopic parathyroid hormone (PTH) production, 2Department of Internal Medicine, American University of ectopic production of 1, 25-(OH)2 vitamin D by the tumor and its adjacent macrophages and Beirut-Medical Center, Lebanon bone metastasis which by itself in addition to the local production of PTHrP at the level of the bone lead to bone resorption and thus hypercalcemia. Treatment includes extracellular Correspondence: Asma Arabi, Department of Internal fluid volume repletion, bisphosphonates or denosumab and calcitonin. Ectopic Cushing’s Medicine, Division of Endocrinology, American University of syndrome caused by ectopic ACTH production results in hypokalemia, proximal muscle Beirut-Medical Center, Po Box 11-0236, Riad El-Solh, Beirut, weakness, easy bruisability, hypertension, diabetes and psychiatric abnormalities including Lebanon, Email depression and mood disorders. Different diagnostic measures help to differentiate Cushing’s disease from ectopic Cushing’s syndrome. Treatment includes surgical resection Received: October 26, 2014 | Published: January 02, 2015 of tumor and medical therapy to suppress excess cortisol production. Ectopic secretion of ADH has been associated with different tumor types. The best treatment options include removal of the underlying tumor, chemotherapy, or radiotherapy in addition to free water restriction, demeclocycline and vaptans. -
TGF-Β Signaling Proteins and CYP24A1 May Serve As Surrogate
1437 Original Article TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types Ana Paucarmayta1, Hannah Taitz1, Yovanni Casablanca1,2,3, Gustavo C. Rodriguez4, G. Larry Maxwell2,3,5, Kathleen M. Darcy2,3,6, Viqar Syed1,3,7 1Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; 2Gynecologic Cancer Center of Excellence, 3John P. Murtha Cancer Center, Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, MD, USA; 4Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, IL, USA; 5Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Falls Church, VA, USA; 6Inova Schar Cancer Institute, Inova Center for Personalized Health, Falls Church, VA, USA; 7Department of Molecular and Cell Biology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA Contributions: (I) Conception and design: KM Darcy, GL Maxwell, V Syed; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: A Paucarmayta, H Taitz, V Syed; (V) Data analysis and interpretation: A Paucarmayta, H Taitz, KM Darcy, V Syed; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Viqar Syed. John P. Murtha Cancer Center, Department of Obstetrics and Gynecology, Department of Molecular and Cell Biology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Room# A-3080, Bethesda, MD, USA. Email: [email protected]. Background: Strategies are needed to coordinately block drivers and induce suppressors of cancer to reduce incidence and improve outcomes for individuals with inherited or acquired risk. -
Concept of Diabetes in Unani System of Medicine: an Overview
Original Article Endocrinology Medical Journal of Islamic World Academy of Sciences Concept of Diabetes in Unani System of Medicine: An Overview M. Nazamuddin1, Abdul Wadud1, Abdul H. Ansari2, Tanwir Alam3, Aisha Perveen1, Nafis Iqbal4 1Department of Ilmul Advia (Pharmacology), National Institute of Unani Medicine (NIUM), Bangalore-91, Karnataka, India. 2Department. of Preventive and Social Medicine, National Institute of Unani Medicine (NIUM), Bangalore-91, Karnataka, India. 3Department of Preventive and Social Medicine, Allama Iqbal Unani Medical College (AIUMC), Muzaffarnagar, U.P., India. 4Dept of Kulliyat (Basic Science), Jamia Tibbiya Deoband, Saharanpur, U.P., India. ABSTRACT Diabetes is one of the top killer diseases of mankind. Although it affects all the sect of society, its impact is mainly on affluent society. The today’s description of diabetes has almost stabilized, which mainly revolves around the role of pancreas, insulin, and its peripheral resistance along with other causes, to a lesser extent; however, this description needs reconsideration. The accelerating burden of the disease reveals that even the recent remarkable advancement in medical sciences does not have a justifiable answer to tackle and cease its ever-increasing load; therefore, there is a need of time to rethink about the preventive strategies, line of treatment, management, and all aspects of diabetes. However, various complementary and alternative medicine (CAM) therapy claiming attractive concepts and line of management are in vogue. Unani system of medicine (USM) is the oldest among CAM, which has an entirely different and promising concept to understand all aspects of diabetes and offer a range of drugs to counter this disease. Unani physicians and philosophers have an entirely different insight of this disease. -
Vitamin D3 Constrains Estrogen's Effects and Influences Mammary
www.nature.com/scientificreports OPEN Vitamin D3 constrains estrogen’s efects and infuences mammary epithelial organization in 3D Received: 16 January 2019 Accepted: 18 April 2019 cultures Published: xx xx xxxx Nafs Hasan 1, Carlos Sonnenschein1,2 & Ana M. Soto 1,2 Vitamin D3 (vitD3) and its active metabolite, calcitriol (1,25-(OH)2D3), afect multiple tissue types by interacting with the vitamin D receptor (VDR). Although vitD3 defciency has been correlated with increased incidence of breast cancer and less favorable outcomes, randomized clinical trials have yet to provide conclusive evidence on the efcacy of vitD3 in preventing or treating breast cancer. Additionally, experimental studies are needed to assess the biological plausibility of these outcomes. The mammary gland of VDR KO mice shows a forid phenotype revealing alterations of developmental processes that are largely regulated by mammotropic hormones. However, most research conducted on vitD3’s efects used 2D cell cultures and supra-physiological doses of vitD3, conditions that spare the microenvironment in which morphogenesis takes place. We investigated the role of vitD3 in mammary epithelial morphogenesis using two 3D culture models. VitD3 interfered with estrogen’s actions on T47D human breast cancer cells in 3D diferently at diferent doses, and recapitulated what is observed in vivo. Also, vitD3 can act autonomously and afected the organization of estrogen-insensitive MCF10A cells in 3D collagen matrix by infuencing collagen fber organization. Thus, vitD3 modulates mammary tissue organization independent of its efects on cell proliferation. Breast cancer remains a major cause of mortality among women worldwide. Epidemiological studies have shown that key stages during breast development are particularly susceptible to the efects of carcinogens. -
Hypoparathyroidism, Sensorineural
Joseph et al. BMC Endocrine Disorders (2019) 19:111 https://doi.org/10.1186/s12902-019-0438-4 CASE REPORT Open Access Hypoparathyroidism, Sensorineural deafness and renal disease (Barakat syndrome) caused by a reduced gene dosage in GATA3: a case report and review of literature Anne D. D. Joseph1* , Nirmala D. Sirisena2, Thirunavukarasu Kumanan1, Vathualan Sujanitha1, Veronika Strelow3, Raina Yamamoto3, Stefan Wieczorek3 and Vajira H. W. Dissanayake2 Abstract Background: Barakat syndrome is an autosomal dominant rare genetic disease caused by haploinsufficiency of the GATA binding protein 3 (GATA3) gene. It is also known as HDR syndrome, and is characterized by varying degrees of hypoparathyroidism, sensorineural deafness and renal disease. This is the first report of a heterozygous GATA3 whole gene deletion causing HDR syndrome in a Sri Lankan family. Case presentation: A 13-year-old boy with an acute febrile illness, hypocalcaemia and bilateral carpopedal spasm was referred for evaluation. A past medical history of treatment for persistent hypocalcaemic symptoms since the age of 7 months was obtained. Biochemical investigations showed persistent low serum corrected calcium levels with hyperphosphataemia, hypomagnesaemia, low parathyroid hormone levels, hypercalciuria, and low total 25-hydroxy vitamin D levels. His renal functions and renal sonography were normal. Audiometry showed bilateral moderate to severe sensorineural hearing loss. On screening, his mother was also found to have asymptomatic hypocalcaemia, hypomagnesaemia, hyperphosphataemia, hypercalciuria and low total 25-hydroxy vitamin D levels. She had impaired renal functions and chronic parenchymal changes in the renal scan. Audiometry showed bilateral profound sensorineural hearing loss. Genetic analysis using multiplex-ligation dependent probe amplification showed a reduced gene dosage for GATA3 that is consistent with a heterozygous whole gene deletion in both the child and mother.